Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (641-650 of 831) with videos related to

Pageof 84
Sort By:
European Urology|July 26, 2016
Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative AnalysisAmar U Kishan, Talha Shaikh, Pin-Chieh Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Institutional clinical trial accrual volume and survival of patients with head and neck cancerEvan J Wuthrick, Qiang Zhang, Mitchell Machtay, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell MalignancyXinxin Wang, Andrew E Cornish, Mytrang H Do, et al.
The Canadian Journal of Urology|December 21, 2016
Patient reported outcomes among treatment modalities for prostate cancerMatthew E Johnson, Nicholas G Zaorsky, Jeffrey M Martin, et al.
Leukemia & Lymphoma|February 8, 2025
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphomaSteven M Horwitz, Tatyana A Feldman, Jing Christine Ye, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
A look at rheumatology in China (2002)Lan X Chen, Robert Eberhardt, Robert J Enzenauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2025
ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancerJyoti S Mayadev, Kevin V Albuquerque, Jeremy G Price, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2022
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate CancerEddie Zhang, Karen J Ruth, Mark K Buyyounouski, et al.
Blood Cancer Journal|November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological featuresKimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Cancer|July 26, 2017
Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancerDavid B Cahn, Elizabeth A Handorf, Eric M Ghiraldi, et al.
Pageof 84

Showing results (641-650 of 831) with videos related to

Sort By:
Pageof 84
European Urology|July 26, 2016
Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative AnalysisAmar U Kishan, Talha Shaikh, Pin-Chieh Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Institutional clinical trial accrual volume and survival of patients with head and neck cancerEvan J Wuthrick, Qiang Zhang, Mitchell Machtay, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell MalignancyXinxin Wang, Andrew E Cornish, Mytrang H Do, et al.
The Canadian Journal of Urology|December 21, 2016
Patient reported outcomes among treatment modalities for prostate cancerMatthew E Johnson, Nicholas G Zaorsky, Jeffrey M Martin, et al.
Leukemia & Lymphoma|February 8, 2025
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphomaSteven M Horwitz, Tatyana A Feldman, Jing Christine Ye, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
A look at rheumatology in China (2002)Lan X Chen, Robert Eberhardt, Robert J Enzenauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2025
ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancerJyoti S Mayadev, Kevin V Albuquerque, Jeremy G Price, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2022
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate CancerEddie Zhang, Karen J Ruth, Mark K Buyyounouski, et al.
Blood Cancer Journal|November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological featuresKimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Cancer|July 26, 2017
Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancerDavid B Cahn, Elizabeth A Handorf, Eric M Ghiraldi, et al.
Pageof 84